Skip to content
The Policy VaultThe Policy Vault

Thalomid (thalidomide)Medica

Cutaneous lupus erythematosus

Initial criteria

  • Patient has tried at least two other medications (e.g., corticosteroids [oral, topical, intralesional], antimalarial agents such as hydroxychloroquine, topical calcineurin inhibitors, azathioprine, cyclosporine, mycophenolate mofetil, methotrexate, dapsone, acitretin)

Approval duration

1 year